文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Comprehensive malnutritional index for predicting clinical outcomes in locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.

作者信息

Xu Yu, Shen Peipei, Zhu Jiahao, Qian Danqi, Gu Ke, Mao Yong, Ji Shengjun, Yang Bo, Zhao Yutian

机构信息

Department of Radiotherapy and Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, China; Wuxi Clinical Cancer Center, Wuxi, China.

Wuxi Clinical Cancer Center, Wuxi, China; Department of Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, China.

出版信息

Biomol Biomed. 2025 Apr 3;25(5):1079-1091. doi: 10.17305/bb.2024.11188.


DOI:10.17305/bb.2024.11188
PMID:39508747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11984360/
Abstract

The objective of this investigation was to assess the prognostic significance of the comprehensive malnutritional index (CNI) in patients with locally advanced rectal cancer (LARC) who underwent neoadjuvant chemoradiotherapy (nCRT) followed by surgery. A total of 240 LARC patients were recruited. The CNI was calculated using principal components analysis based on hemoglobin (Hb), total lymphocyte count (TLC), albumin (ALB), body mass index (BMI), and usual body weight percentage (UBW%). The patients were then categorized into two groups based on the median CNI value. Cox regression and survival analyses were performed. The CNI-low (120 cases) and CNI-high (120 cases) groups were classified based on the median CNI value. The results indicated that the CNI demonstrated superior predictive ability for disease-free survival (DFS) and overall survival (OS) compared to other malnutritional indexes. LARC patients in the CNI-high group had significantly longer DFS and OS compared to those in the CNI-low group. Multivariate analysis revealed that the CNI was an independent prognostic factor for DFS (hazard ratio [HR] = 0.49; 95% confidence interval [CI], 0.29-0.83; P = 0.008) and OS (HR = 0.30; 95% CI, 0.16-0.58; P < 0.001). Additionally, the CNI-high group benefited from postoperative chemotherapy (DFS: P = 0.029, OS: P = 0.024), while the CNI-low group did not show such benefits (DFS: P = 0.448, OS: P = 0.468). These findings suggest that the CNI could serve as a valuable prognostic indicator for LARC patients who undergo nCRT followed by surgery. Preoperative nutrition optimization is important for LARC patients.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/84123e22fcf8/bb-2024-11188f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/99d01b44fcba/bb-2024-11188f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/2e3cbae0f647/bb-2024-11188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/8729b6bfff87/bb-2024-11188f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/84123e22fcf8/bb-2024-11188f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/99d01b44fcba/bb-2024-11188f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/2e3cbae0f647/bb-2024-11188f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/8729b6bfff87/bb-2024-11188f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e9/11984360/84123e22fcf8/bb-2024-11188f4.jpg

相似文献

[1]
Comprehensive malnutritional index for predicting clinical outcomes in locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.

Biomol Biomed. 2025-4-3

[2]
The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.

Biomol Biomed. 2024-5-2

[3]
Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs.

Int J Colorectal Dis. 2024-6-19

[4]
Alteration of Apparent Diffusion Coefficient Measurements Predict Survival Outcomes During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

In Vivo. 2025

[5]
Pathomics-based machine learning models for predicting pathological complete response and prognosis in locally advanced rectal cancer patients post-neoadjuvant chemoradiotherapy: insights from two independent institutional studies.

BMC Cancer. 2024-12-26

[6]
Nutritional and inflammatory status dynamics reflect preoperative treatment response and predict prognosis in locally advanced rectal cancer: A retrospective multi-institutional analysis.

Surgery. 2025-2

[7]
Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer.

Biomol Biomed. 2025-4-3

[8]
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.

BMC Cancer. 2019-7-5

[9]
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.

Ann Oncol. 2015-7-30

[10]
Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.

J Gastrointest Surg. 2021-4

引用本文的文献

[1]
Prognostic Nutritional Index as a Predictor of Surgical Morbidity in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

J Clin Med. 2025-3-13

本文引用的文献

[1]
National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data.

Lancet Public Health. 2023-12

[2]
Efficacy of the Geriatric Nutritional Risk Index for Predicting Overall Survival in Patients with Head and Neck Cancer: A Meta-Analysis.

Nutrients. 2023-10-12

[3]
Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy.

Int Immunopharmacol. 2023-8

[4]
Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?

Front Immunol. 2023

[5]
The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients.

Front Immunol. 2023

[6]
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies.

Nutrients. 2023-2-1

[7]
Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.

Cells. 2023-1-26

[8]
Integrated Intensified Chemoradiation in the Setting of Total Neoadjuvant Therapy (TNT) in Patients with Locally Advanced Rectal Cancer: A Retrospective Single-Arm Study on Feasibility and Efficacy.

Cancers (Basel). 2023-2-1

[9]
Cancer statistics, 2023.

CA Cancer J Clin. 2023-1

[10]
The preoperative geriatric nutritional risk index predicts long-term prognosis in elderly locally advanced rectal cancer patients: a two-center retrospective cohort study.

Aging Clin Exp Res. 2023-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索